Combination treatment of TRPV4 agonist with cisplatin promotes vessel normalization in an animal model of oral squamous cell carcinoma
Oral squamous cell carcinoma (OSCC) is the sixth most common malignancy in the world. Transient receptor potential vanilloid 4 (TRPV4) channel has been shown to be involved in angiogenesis in multiple types of tumors. However, not much is known about TRPV4 ` s involvement in OSCC. Thus, in this stud...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41329/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!